Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.53 USD | +0.28% | +10.66% | -9.47% |
May. 09 | HilleVax, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 05 | Hillevax Insider Sold Shares Worth $264,467, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.47% | 690M | |
+44.48% | 55.07B | |
+43.57% | 40.22B | |
-0.86% | 41.79B | |
-7.59% | 28.17B | |
+12.30% | 26.28B | |
-21.83% | 18.93B | |
+7.15% | 13.03B | |
+29.40% | 12.26B | |
+25.15% | 12.21B |
- Stock Market
- Equities
- HLVX Stock
- News HilleVax, Inc.
- Kanghua Biological Products Licenses Norovirus Vaccine to HilleVax